Schottelius M - Search Results

1

CXCR4-directed theranostics in oncology and inflammation.

Kircher M, Herhaus P, Schottelius M, Buck AK, Werner RA, Wester HJ, Keller U, Lapa C. Kircher M, et al. Among authors: schottelius m. Ann Nucl Med. 2018 Oct;32(8):503-511. doi: 10.1007/s12149-018-1290-8. Epub 2018 Aug 13. Ann Nucl Med. 2018. PMID: 30105558 Free PMC article. Review.

2

Site-selective template-directed synthesis of antibody Fc conjugates with concomitant ligand release.

Postupalenko V, Marx L, Pantin M, Viertl D, Gsponer N, Giudice G, Gasilova N, Schottelius M, Lévy F, Garrouste P, Segura JM, Nyanguile O. Postupalenko V, et al. Among authors: schottelius m. Chem Sci. 2023 Dec 14;15(4):1324-1337. doi: 10.1039/d3sc04324j. eCollection 2024 Jan 24. Chem Sci. 2023. PMID: 38274063 Free PMC article.

3

Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: the effect of carbohydration on the pharmacokinetics.

Wester HJ, Schottelius M, Scheidhauer K, Reubi JC, Wolf I, Schwaiger M. Wester HJ, et al. Among authors: schottelius m. Eur J Nucl Med Mol Imaging. 2002 Jan;29(1):28-38. doi: 10.1007/s00259-001-0669-1. Epub 2001 Nov 1. Eur J Nucl Med Mol Imaging. 2002. PMID: 11807604

4

Improvement of pharmacokinetics of radioiodinated Tyr(3)-octreotide by conjugation with carbohydrates.

Schottelius M, Wester HJ, Reubi JC, Senekowitsch-Schmidtke R, Schwaiger M. Schottelius M, et al. Bioconjug Chem. 2002 Sep-Oct;13(5):1021-30. doi: 10.1021/bc0200069. Bioconjug Chem. 2002. PMID: 12236784

5

Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs.

Poethko T, Schottelius M, Thumshirn G, Hersel U, Herz M, Henriksen G, Kessler H, Schwaiger M, Wester HJ. Poethko T, et al. Among authors: schottelius m. J Nucl Med. 2004 May;45(5):892-902. J Nucl Med. 2004. PMID: 15136641 Free article.

6

First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.

Schottelius M, Poethko T, Herz M, Reubi JC, Kessler H, Schwaiger M, Wester HJ. Schottelius M, et al. Clin Cancer Res. 2004 Jun 1;10(11):3593-606. doi: 10.1158/1078-0432.CCR-03-0359. Clin Cancer Res. 2004. PMID: 15173065

7

Radiolabeled carbohydrated somatostatin analogs: a review of the current status.

Wester HJ, Schottelius M, Poethko T, Bruus-Jensen K, Schwaiger M. Wester HJ, et al. Among authors: schottelius m. Cancer Biother Radiopharm. 2004 Apr;19(2):231-44. doi: 10.1089/108497804323072011. Cancer Biother Radiopharm. 2004. PMID: 15186604 Review.

8

Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry.

Schottelius M, Rau F, Reubi JC, Schwaiger M, Wester HJ. Schottelius M, et al. Bioconjug Chem. 2005 Mar-Apr;16(2):429-37. doi: 10.1021/bc0499228. Bioconjug Chem. 2005. PMID: 15769098

9

N-terminal sugar conjugation and C-terminal Thr-for-Thr(ol) exchange in radioiodinated Tyr3-octreotide: effect on cellular ligand trafficking in vitro and tumor accumulation in vivo.

Schottelius M, Reubi JC, Eltschinger V, Schwaiger M, Wester HJ. Schottelius M, et al. J Med Chem. 2005 Apr 21;48(8):2778-89. doi: 10.1021/jm040794i. J Med Chem. 2005. PMID: 15828816

10

Chemoselective hydrazone formation between HYNIC-functionalized peptides and (18)F-fluorinated aldehydes.

Bruus-Jensen K, Poethko T, Schottelius M, Hauser A, Schwaiger M, Wester HJ. Bruus-Jensen K, et al. Among authors: schottelius m. Nucl Med Biol. 2006 Feb;33(2):173-83. doi: 10.1016/j.nucmedbio.2005.10.010. Nucl Med Biol. 2006. PMID: 16546671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters